Financial Summary (All financials)
In millions, except per share items | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 |
Revenues | 180.5 | 178.0 | 157.8 | 141.8 | 125.1 |
Revenue growth | 1.4% | 12.8% | 11.3% | 13.3% | |
Cost of goods sold | 43.0 | 41.5 | 37.6 | 98.3 | 0.0 |
Gross profit | 137.5 | 136.5 | 120.2 | 43.5 | 125.1 |
Gross margin | 76.2% | 76.7% | 76.2% | 30.7% | 100.0% |
Sales and marketing | 76.3 | 75.0 | 67.1 | 61.4 | 60.9 |
Research and development | 49.8 | 51.1 | 41.9 | 34.6 | 18.3 |
General and administrative | 22.7 | 23.1 | 25.1 | 18.9 | 19.3 |
EBITA | 18.3 | 16.7 | 9.7 | 10.3 | -1.8 |
EBITA margin | 10.1% | 9.4% | 6.1% | 7.3% | -1.5% |
Amortization of intangibles | 4.4 | 3.7 | 2.7 | | |
EBIT | 13.9 | 13.0 | 7.0 | 10.3 | -1.8 |
EBIT margin | 7.7% | 7.3% | 4.4% | 7.3% | -1.5% |
Pre-tax income | 14.7 | 14.3 | 9.6 | 11.9 | 2.2 |
Income taxes | 0.0 | 0.0 | 0.0 | 1.5 | 0.3 |
Tax rate | 0.0% | 0.0% | 0.0% | 13.0% | 11.5% |
Net income | 14.3 | 12.2 | 8.2 | 13.4 | 1.9 |
Net margin | 7.9% | 6.8% | 5.2% | 9.5% | 1.5% |
|
Diluted EPS | $0.45 | $0.39 | $0.27 | $0.44 | |
Shares outstanding (diluted) | 31.6 | 31.1 | 30.5 | 30.4 | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|